Francis A. Farraye, MD

Adjunct Professor, Medicine

Francis Farraye
617.638.8339
85 E. Concord St

Biography

Dr. Farraye is a Senior Associate Consultant in the Section of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville Florida where he co-directs the Inflammatory Bowel Disease Center. Prior to relocating in 2019, he was Clinical Director in the Section of Gastroenterology and the Inflammatory Bowel Disease Center at Boston Medical Center. At Boston University School of Medicine, he was Professor of Medicine. Dr. Farraye earned his medical doctorate from the Albert Einstein College of Medicine in New York and his master’s degree in Epidemiology from the Harvard School of Public Health.

Dr. Farraye’s clinical interests are in the care of patients with inflammatory bowel disease. He is currently investigating C. difficile infection in IBD patients, the management and diagnosis of dysplasia and cancer in patients with IBD; social media use and health literacy in IBD patients; hepatitis B vaccination efficacy in patients with IBD; and subclinical hepatic fibrosis in patients with IBD.

A frequent speaker and invited lecturer on topics on the diagnosis and management of inflammatory bowel disease, Dr. Farraye has authored or co-authored over 450 original scientific manuscripts, book chapters, reviews, and abstracts. He is the series editor for the text Curbside Consultations in Gastroenterology and co-edited the text, Curbside Consultation in Inflammatory Bowel Disease and Gastrointestinal Emergencies. His books for patients include Questions and Answers about Ulcerative Colitis, Questions and Answers about Crohn’s Disease and Ulcerative Colitis for Dummies.

Dr. Farraye is a Fellow of the American Society of Gastrointestinal Endoscopy, American Gastroenterological Association and the American College of Gastroenterology. He has served on numerous national and international committees including as a member of the ACG Board of Trustees. He is co-chair of the Crohn’s and Colitis Foundation Membership Committee and a member of the Chapter Medical Advisory Committee for the New England Crohn’s and Colitis Foundation and a past chairman. The New England Crohn’s and Colitis Foundation named Dr. Farraye Humanitarian of the Year in 2003. In 2009, the ACG awarded Dr. Farraye the William Carey Award for service to the college. Dr. Farraye has been recognized as “Top Doctor” in Gastroenterology by Boston Magazine and U.S. News and World Report since 2010.

Other Positions

  • Active Staff Privileges, Medicine, Boston Medical Center

Education

  • Albert Einstein College of Medicine, MD
  • Harvard School of Public Health, MSc
  • Stony Brook University, BS

Publications

  • Published on 8/20/2019

    Caldera F, Farraye FA, Rosh JR, Hayney MS. Prudence Using Serology to Determine Vaccine-Induced Immunity to Measles and Varicella in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019 Aug 20; 25(9):e113. PMID: 31165856.

    Read at: PubMed
  • Published on 7/1/2019

    Feuerstein JD, Moss AC, Farraye FA. Ulcerative Colitis. Mayo Clin Proc. 2019 Jul; 94(7):1357-1373. PMID: 31272578.

    Read at: PubMed
  • Published on 6/7/2019

    Boden EK, Canavan JB, Moran CJ, McCann K, Dunn WA, Farraye FA, Ananthakrishnan AN, Yajnik V, Gandhi R, Nguyen DD, Bhan AK, Weiner HL, Korzenik JR, Snapper SB. Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis. Crohns Colitis 360. 2019 Jul; 1(2):otz009. PMID: 31423487.

    Read at: PubMed
  • Published on 4/11/2019

    Qazi T, Farraye FA. Sleep and Inflammatory Bowel Disease: An Important Bi-Directional Relationship. Inflamm Bowel Dis. 2019 Apr 11; 25(5):843-852. PMID: 30388243.

    Read at: PubMed
  • Published on 4/11/2019

    Chudy-Onwugaje KO, Christian KE, Farraye FA, Cross RK. A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD. Inflamm Bowel Dis. 2019 Apr 11; 25(5):820-830. PMID: 30445504.

    Read at: PubMed
  • Published on 4/3/2019

    Pratt PK, Nunes D, Long MT, Farraye FA. Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2019 Jul; 64(7):2031-2038. PMID: 30945037.

    Read at: PubMed
  • Published on 3/16/2019

    Limdi JK, Farraye J, Cannon R, Woodhams E, Farraye FA. Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: What Clinicians (and Patients) Should Know. Inflamm Bowel Dis. 2019 Mar 16. PMID: 30877770.

    Read at: PubMed
  • Published on 2/21/2019

    Reich J, Guo L, Groshek J, Weinberg J, Chen W, Martin C, Long MD, Farraye FA. Social Media Use and Preferences in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019 02 21; 25(3):587-591. PMID: 30203036.

    Read at: PubMed
  • Published on 2/21/2019

    Apte M, Reich J, Zahorian T, Farraye FA. Improving Vaccination Rates for IBD Patients Through the Use of Local Pharmacies. Inflamm Bowel Dis. 2019 02 21; 25(3):e19. PMID: 29893866.

    Read at: PubMed
  • Published on 2/8/2019

    Bhat S, Zahorian T, Robert R, Farraye FA. Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process. Inflamm Bowel Dis. 2019 Feb 08. PMID: 30753551.

    Read at: PubMed

View 321 more publications: View full profile at BUMC

View all profiles